2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Pharmacokinetic Evaluation of Astagraf XL® and Prograf® in Renal Transplant Candidates Following Laparoscopic Sleeve Gastrectomy.

A. Lichvar,¹ A. Leino,¹ T. Kaiser,¹ T. Mizuno,² T. Fukuda,² U. Christians,¹ R. Alloway,¹ A. Vinks,² E. Woodle,¹ T. Diwan.¹
Pharmakokinetics of Prolonged-Release Formulation of Tacrolimus: Comparison of AUC0-24 and Concentration at 10 Time Points.

K. Unagami,¹ M. Okumi,² M. Furusawa,² T. Hirai,² T. Shimizu,² K. Omoto,² M. Inui,² H. Ishida,² K. Nitta,¹ K. Tanabe.²
Phenotype and Outcome of Antibody-Mediated Rejection Due to Pre-Existing and De Novo DSA in Kidney Recipients.

O. Aubert,¹ A. Loupy,¹ L. Hidalgo,² J. Reeve,³ D. Glotz,¹ C. Legendre,¹ C. Lefaucheur,¹ P. Halloran.³
Physical Disability on the Liver Transplant Waitlist: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.

M. Samoylova, M. Haftek, S. Shiboski, K. Covinsky, J. Roberts, J. Lai.
Planning Genitourinary Vascularized Composite Allotransplantation: A Pre-Operative Imaging Protocol.

I. Schol, T. Drijkoningen, G. Choy, R. Liu, C. Tanrikut, P. Holzer, D. Ko, C. Cetrulo.
Plasma Alemtuzumab Levels Show Great Interpatient Variability, but Are Not Associated with Late Acute Rejection in Simultaneous Pancreas-Kidney Recipients.

J. Bank,¹ M. Mallat,¹ C. Jol-van der Zijde,² R. Bredius,² P. van der Boog,¹ A. Braat,³ J. Ringers,³ M. Reinders,¹ J. de Fijter.¹
Plasma Cell Frequency in Renal Rejection After Treatment with Alemtuzumab.

L. Mugge, A. Zimmerman, N. Varshney, A. Gohara, M. Rees, J. Ortiz.
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.

D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²
Pneumocystis Pneumonia Following Solid Organ Transplantation, Systematic Review and Meta-Analysis.

S. Hosseini-Moghaddam,^1,2 R. Krishnan.²
Polyclonal Treg Adoptive Therapy for Control of Subclinical Kidney Transplant Inflammation (TASK Pilot Trial).

S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z